According to the data of China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), China’s export of western medicine preparations to the U.S. exceeded USD 90 million in 2018 Q1, wherein, the total export of the top 5: Hengrui Medicine, Huahai Pharmaceutical, Novast, Humanwell Healthcare, and Qilu Pharmaceutical accounted for 67% thereof.

Huahai Pharmaceutical, Hengrui Medicine, and CSPC continued to be among the top 5 by annual preparation export in the past three years. From the perspective of the global generic drug market, the EU, U.S., and China are the top 3 generic drug consumers in the world. Chinese pharmaceutical enterprises’ export of western medicine preparations has shown a rising trend in recent years as they receive more and more U.S. ANDA approvals.
Concentrated approvals, small overall scale of preparation export
According to report, the road of Chinese pharmaceutical enterprises’ application with FDA can be traced back to 1974 when Humanwell PuraCap Pharmaceuticals applied for Methocarbamol Tablets (removed from market), and in 1979 that followed, Huahai Pharmaceutical also started its overseas application road with FDA with methocarbamol.
Chinese pharmaceutical enterprises had a total of 278 U.S. ANDA approvals by August 20, including 255 approvals and 23 pre-approvals.
The approvals of the top 9 Chinese pharmaceutical enterprises totaled 243, centralizing 87.4% of the total, wherein, Huahai Pharmaceutical, Humanwell Healthcare, and Fosun Pharma were the top 3, followed by Novast and Hengrui Medicine.
|
No. |
Pharmaceutical enterprise |
Number of ANDAs |
Number of approvals |
Number of pre-approvals |
|
1 |
Huahai Pharmaceutical |
58 |
54 |
4 |
|
2 |
Humanwell Healthcare |
49 |
49 |
0 |
|
3 |
Fosun Pharma |
41 |
40 |
1 |
|
4 |
Novast |
34 |
32 |
2 |
|
5 |
Hengrui Medicine |
16 |
15 |
1 |
|
6 |
CSPC Ouyi |
15 |
12 |
3 |
|
7 |
Hisun Pharmaceuticals |
Read More
Related News
With an annual sales volume of RMB 666 million, Sevelamer Carbonate Tablets of Dr. Reddy's Laboratories were approved in China
Caicai/PharmaSources May 22, 2023
Meridian Lab and Apobiologix to Develop Docetaxel Injection
americanpharmaceuticalreview February 6, 2017
Janssen Human Microbiome Institute Announces Multiple Collaborations to Accelerate the Translation o
americanpharmaceuticalreview February 6, 2017 You may like
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation! Subscribe
Note: You can unsubscribe from the alerts at any time. Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation! Subscribe
Note: You can unsubscribe from the alerts at any time. Most popular
Apeloa Pharmaceutical releases first ESG
PharmaSources
May 12, 2025
Basic Concepts and Latest Trends in Radiation Biology: Emerging Insights and Future Directions
Sadia Ajmal
Sep 18, 2025
Methodology Validation in Chinese Pharmacopoeia 2025: How to Report Accuracy and Precision
Xing Xing
Sep 12, 2025
Digitalization in Procurement: From AI Forecasting to Blockchain Traceability
Saher Haider
Sep 19, 2025
|









(All Rights Reserved)